Fecal Microbiota Transplantation for Ulcerative Colitis. Are We Ready for Primetime?
- PMID: 33121693
- DOI: 10.1016/j.gtc.2020.08.006
Fecal Microbiota Transplantation for Ulcerative Colitis. Are We Ready for Primetime?
Abstract
"Patients with inflammatory bowel disease, including ulcerative colitis (UC) and Crohn disease, have altered gut microbiomes. The success of fecal microbiota transplantation (FMT) in the treatment of Clostridioides difficile infection, a disease that is also marked by dysbiosis, has spurred research in applying FMT to UC. So far, 3 randomized controlled trials have demonstrated benefit in mild to moderate UC disease course after FMT. However, important questions regarding optimal stool preparation, route, and frequency of administration, as well as characteristics of the stool donor and recipient still remain."
Keywords: Clostridioides difficile infection; Fecal microbiota transplantation; Inflammatory bowel disease; Microbiome; Ulcerative colitis.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of interest disclosures M. Fischer serves as consultant for Finch Therapeutics Group and DSMB member for Rebiotix. Y.W. Cheng has nothing to disclose.
Similar articles
-
Fecal microbiota transplantation for ulcerative colitis.Immunol Med. 2021 Mar;44(1):30-34. doi: 10.1080/25785826.2020.1792040. Epub 2020 Jul 14. Immunol Med. 2021. PMID: 32663072 Review.
-
Fecal microbiota transplantation in ulcerative colitis.Acta Gastroenterol Belg. 2019 Oct-Dec;82(4):519-528. Acta Gastroenterol Belg. 2019. PMID: 31950808 Review.
-
Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: an update.Drugs Today (Barc). 2018 Feb;54(2):123-136. doi: 10.1358/dot.2018.54.2.2760765. Drugs Today (Barc). 2018. PMID: 29637938 Review.
-
Gut microbiota in ulcerative colitis: insights on pathogenesis and treatment.J Dig Dis. 2020 Mar;21(3):147-159. doi: 10.1111/1751-2980.12849. J Dig Dis. 2020. PMID: 32040250 Review.
-
Fecal transplantation for ulcerative colitis: current evidence and future applications.Expert Opin Biol Ther. 2020 Apr;20(4):343-351. doi: 10.1080/14712598.2020.1733964. Epub 2020 Feb 26. Expert Opin Biol Ther. 2020. PMID: 32083498 Review.
Cited by
-
Qingchang Wenzhong Decoction Accelerates Intestinal Mucosal Healing Through Modulation of Dysregulated Gut Microbiome, Intestinal Barrier and Immune Responses in Mice.Front Pharmacol. 2021 Sep 7;12:738152. doi: 10.3389/fphar.2021.738152. eCollection 2021. Front Pharmacol. 2021. PMID: 34557102 Free PMC article.
-
3-oxo-C12:2-HSL, quorum sensing molecule from human intestinal microbiota, inhibits pro-inflammatory pathways in immune cells via bitter taste receptors.Sci Rep. 2022 Jun 8;12(1):9440. doi: 10.1038/s41598-022-13451-3. Sci Rep. 2022. PMID: 35676403 Free PMC article.
-
Efficacy and safety of fecal microbiota transplantation for treatment of ulcerative colitis: A post-consensus systematic review and meta-analysis.World J Clin Cases. 2024 Jul 26;12(21):4691-4702. doi: 10.12998/wjcc.v12.i21.4691. World J Clin Cases. 2024. PMID: 39070844 Free PMC article.
-
Siderophore-harboring gut bacteria and fecal siderophore genes for predicting the responsiveness of fecal microbiota transplantation for active ulcerative colitis.J Transl Med. 2024 Jun 24;22(1):589. doi: 10.1186/s12967-024-05419-w. J Transl Med. 2024. PMID: 38915068 Free PMC article.
-
Cross Talk between Gut Microbiota and Intestinal Mucosal Immunity in the Development of Ulcerative Colitis.Infect Immun. 2021 Aug 16;89(9):e0001421. doi: 10.1128/IAI.00014-21. Epub 2021 Aug 16. Infect Immun. 2021. PMID: 33526559 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical